Skip to content

Rts Technology, Inc.

United StatesFDA applicant, unverified

Devices
3

What Rts Technology, Inc. makes

Rts Technology, Inc. manufactures high-dose rate (HDR) remote afterloaders, including the GammaMed 12IT system, for brachytherapy applications in radiation oncology. Their portfolio includes iridium-192 radioactive sources and associated afterloading devices, such as the RTS Technology Models 721, 722, 723, and 724, designed for precise internal radiation treatment delivery.

These devices are classified as Class II under FDA regulations and are supported by 510(k) clearance records. The company’s products are listed in the FDA’s 510(k) database, reflecting their authorised status for commercial distribution in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue3

Newest first, rows 1-3 of 3

Frequently asked questions

How many devices does Rts Technology, Inc. have in the registry?

The registry currently lists 3 devices for Rts Technology, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Rts Technology, Inc.'s devices?

Among its 3 most recently registered devices, Rts Technology, Inc. has devices listed in FDA 510(k) (3 devices).

What risk classes do Rts Technology, Inc.'s devices fall under?

Among its 3 most recently registered devices, the classes recorded for Rts Technology, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Rts Technology, Inc. in the registry?

The most recently registered devices listed for Rts Technology, Inc. include GAMMAMED 12IT HIGH DOSE RATE REMOTE AFTERLOADER, RTS TECHNOLOGY IRIDIUM 192 SOURCES and RTS TECHNOLOGY MODELS 721, 722, 723, 724.

Generated automatically from registry data and not verified by a human reviewer.